{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T10:05:46Z","timestamp":1782122746801,"version":"3.54.5"},"reference-count":78,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>The term \u201clarynx organ preservation\u201d (LOP) has become a synonym for non-surgical laryngeal cancer treatment based on chemotherapy and radiation multimodality therapy [simultaneous chemoradiation (CRT) or neoadjuvant chemotherapy followed by radiotherapy (NCT+RT)]. Currently, the distinction between good and bad candidates for LOP is not clear, and the decision for surgical or non-surgical treatment depends on the patient\u2019s needs and desires, the experience and recommendation of the surgeon, the philosophy of the institution, and others. Nevertheless, the major disadvantage of LOP by CRT and NCT+RT is the potential need for salvage surgery due to tumor persistence after the application of full per-protocol treatment. Head and neck surgeons worldwide complain that in principle, salvage surgery is frequently possible after CRT but causes major complications and is not feasible in a relevant number of patients. While NCT+RT is globally used to select responders for LOP, NCT alone has not been shown to improve overall survival. Therefore, this procedure has lost its influence in standard head and neck cancer treatment beyond LOP. Recently, NCT as part of the perioperative transoral surgical treatment concept in head and neck cancer is gaining interest again. In addition to conventional chemotherapy, the combination with immune checkpoint inhibitors as a neoadjuvant concept has shown to be effective in non-controlled trials by opening a new door of encouraging treatment options for LOP.<\/jats:p>","DOI":"10.3389\/fonc.2024.1494854","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T07:19:11Z","timestamp":1742195951000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Non-surgical organ preservation and new technologies in laryngeal radiation"],"prefix":"10.3389","volume":"14","author":[{"given":"Andreas","family":"Dietz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Eckel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"deVries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1097\/MLG.0b013e3181620eab","article-title":"The Laryngologist in organ preservation for laryngeal cancer, letter to the editor","volume":"118","author":"Brasnu","year":"2008","journal-title":"Laryngoscope"},{"key":"B2","first-page":"1","article-title":"Functional outcomes following treatment for advanced laryngeal cancer. Part I\u2013Voice preservation in advanced laryngeal cancer. Part II\u2014Laryngectomy rehabilitation: the state of the art in the VA System. Research Speech-Language Pathologists. Department of Veterans Affairs Laryngeal Cancer Study Group","volume":"172","author":"Hillman","year":"1998","journal-title":"Ann Otol Rhinol Laryngol Suppl"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlg.0000236095.97947.26","article-title":"Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival","volume":"116","author":"Hoffman","year":"2006","journal-title":"Laryngoscope"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19840901)54:5<811::AID-CNCR2820540508>3.0.CO;2-E","article-title":"Correlation between response to cisplatinum-combination chemotherapy and subsequent radiotherapy in previously untreated patients with advanced squamous cell cancers of the head and neck","volume":"54","author":"Ensley","year":"1984","journal-title":"Cancer"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199106133242402","article-title":"Induction chemotherapy plus radiation compared with surgery plus ra- diation in patients with advanced laryngeal cancer","volume":"324","year":"1991","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/88.13.890","article-title":"Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group","volume":"88","author":"Lefebvre","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)90011-4","article-title":"Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer","volume":"355","author":"Pignon","year":"2000","journal-title":"Lancet"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.43.6097","article-title":"Long-term results of RTOG 91- 11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer","volume":"31","author":"Forastiere","year":"2013","journal-title":"J Clin Oncol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1200\/JCO.2004.10.911","article-title":"The need for adverse effects reporting standards in oncology clinical trials","volume":"22","author":"Trotti","year":"2004","journal-title":"J Clin Oncol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1093\/jnci\/djp007","article-title":"Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without doce- taxel for larynx preservation","volume":"101","author":"Pointreau","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2015.10.014","article-title":"Induction chemotherapy followed by concurrent radio-chemotherapy versus concurrent radio-chemotherapy alone as treatment of locally advanced squamous cell carcinoma of the head and neck (HNSCC): A meta-analysis of randomized trials","volume":"118","author":"Budach","year":"2016","journal-title":"Radiother Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.07.4559","article-title":"American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer","volume":"24","author":"Pfister","year":"2006","journal-title":"J Clin Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.75.7385","article-title":"Use of larynx-preservation strategies in the treatment of laryngeal cancer: American society of clinical oncology clinical practice guideline update","volume":"36","author":"Forastiere","year":"2018","journal-title":"J Clin Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1097\/COC.0000000000000550","article-title":"Curative-dose chemoradiotherapy versus total laryngectomy for stage T3-T4 squamous cell carcinoma of the larynx: an \"Apples-to-apples\" Analysis of the national cancer database","volume":"42","author":"Bates","year":"2019","journal-title":"Am J Clin Oncol"},{"key":"B15","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13143435","article-title":"Chemoradiotherapy but not radiotherapy alone for larynx preservation in T3. Considerations from a German observational cohort study","volume":"13","author":"Dyckhoff","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1017\/S0022215120002704","article-title":"Treatment outcomes of laryngectomy compared to non-surgical management of T3 laryngeal carcinomas: A 10-year multicentre audit of 179 patients in the northeast of England","volume":"134","author":"Lin","year":"2020","journal-title":"J Laryngol Otol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2008.10.047","article-title":"Larynx Preservation Consensus Panel: Larynx preservation clinical trial design: Key issues and recommendations-a consensus panel summary","volume":"73","author":"Lefebvre","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B18","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.ijrobp.2015.03.004","article-title":"Total laryngectomy versus larynx preservation for T4a larynx cancer: patterns of care and survival outcomes","volume":"92","author":"Grover","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.v121.10","article-title":"Long-term outcomes after surgical or nonsurgical initial therapy for patients with T4 squamous cell carcinoma of the larynx: A 3-decade survey","volume":"121","author":"Rosenthal","year":"2015","journal-title":"Cancer"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/hed.v37.10","article-title":"T3-T4 laryngeal cancer in The Netherlands Cancer Institute; 10-year results of the consistent application of an organ-preserving\/-sacrificing protocol","volume":"37","author":"Timmermans","year":"2015","journal-title":"Head Neck"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.77.8001","article-title":"Different view on larynx preservation evidence-based treatment recommendations","volume":"36","author":"Licitra","year":"2018","journal-title":"J Clin Oncol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1001\/archotol.129.1.44","article-title":"Outcome of salvage total laryng- ectomy following organ preservation therapy","volume":"129","author":"Weber","year":"2003","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1097\/MLG.0b013e3180332e39","article-title":"Free tissue transfer to man- age salvage laryngectomy defects after organ preservation failure","volume":"117","author":"Withrow","year":"2007","journal-title":"Laryngoscope"},{"key":"B24","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1007\/s00405-008-0697-6","article-title":"Current aspects of targeted therapy in head and neck tumors","volume":"265","author":"Dietz","year":"2008","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy332","article-title":"Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal\/hypopharyngeal cancer resectable only by total laryngectomy-final results of the larynx organ preservation trial DeLOS-II","volume":"29","author":"Dietz","year":"2018","journal-title":"Ann Oncol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1433333","article-title":"Is precision medicine the solution to improve organ preservation in laryngeal\/hypopharyngeal cancer? A position paper by the Preserve Research Group","volume":"14","author":"Mattavelli","year":"2024","journal-title":"Front Oncol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa071028","article-title":"Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer","volume":"357","author":"Vermorken","year":"2007","journal-title":"N Engl J Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-008-0846-y","article-title":"Induction chemotherapy with pacli- taxel and cisplatin followed by radiotherapy for larynx organ preserva- tion in advanced laryngeal and hypopharyngeal cancer offers moderate late toxicity outcome (DeLOS-I-trial)","volume":"266","author":"Dietz","year":"2009","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"B29","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdq185","article-title":"Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"21","author":"Gregoire","year":"2010","journal-title":"Ann Oncol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.07.011","article-title":"Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Machiels","year":"2020","journal-title":"Ann Oncol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00419","article-title":"Laryngeal preservation strategies in locally advanced laryngeal and hypopharyngeal cancers","volume":"9","author":"Argiris","year":"2019","journal-title":"Front Oncol"},{"key":"B32","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11030289","article-title":"Open partial horizontal laryngectomies for T3(-)T4 laryngeal cancer: prognostic impact of anterior vs. Posterior laryngeal compartmentalization","volume":"11","author":"Del Bon","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/hed.24424","article-title":"Transoral laser microsurgery as primary treatment for selected T3 glottic and supraglottic cancers","volume":"38","author":"Peretti","year":"2016","journal-title":"Head Neck"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/hed.25176","article-title":"Treatment for T3 to T4a laryngeal cancer by open partial horizontal laryngectomies: prognostic impact of different pathologic tumor subcategories","volume":"40","author":"Succo","year":"2018","journal-title":"Head Neck"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/hed.24408","article-title":"Transoral laser microsurgery for locally advanced (T3-T4a) supraglottic squamous cell carcinoma: sixteen years of experience","volume":"38","author":"Vilaseca","year":"2016","journal-title":"Head Neck"},{"key":"B36","doi-asserted-by":"publisher","first-page":"106887","DOI":"10.1016\/j.oraloncology.2024.106878","article-title":"How reliable is assessment of true vocal cord-arytenoid unit mobility in patients affected by laryngeal cancer? a multi-institutional study on 366 patients from the ARYFIX collaborative group","volume":"155","author":"Ferrari","year":"2024","journal-title":"Oral Oncol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3390\/cancers11010067","article-title":"Prediction of posterior paraglottic space and cricoarytenoid unit involvement in endoscopically T3 glottic cancer with arytenoid fixation by magnetic resonance with surface coils","volume":"11","author":"Ravanelli","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B38","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3390\/cancers11030360","article-title":"Arytenoid fixation in laryngeal cancer: radiological pictures and clinical correlations with respect to conservative treatments","volume":"11","author":"Succo","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.3390\/cancers12082241","article-title":"Laryngeal compartmentalization does not affect the prognosis of T3-T4 laryngeal cancer treated by upfront total laryngectomy","volume":"12","author":"Marchi","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-021-06651-6","article-title":"Open partial horizontal laryngectomy and adjuvant (Chemo)Radiotherapy for laryngeal squamous cell carcinoma: results from a multicenter Italian experience","volume":"278","author":"Muscatello","year":"2021","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.v125.19","article-title":"Comparing surgical and nonsurgical larynx-preserving treatments with total laryngectomy for locally advanced laryngeal cancer","volume":"125","author":"Patel","year":"2019","journal-title":"Cancer"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1177\/01945998211020310","article-title":"Assessing the applicability of the talk score: A modification for concurrent tobacco use during treatment","volume":"166","author":"Johnson","year":"2022","journal-title":"Otolaryngol Head Neck Surg"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-023-03121-9","article-title":"Validation of a prognostic model for predicting larynx preservation outcome (Talk score) in a southern European population","volume":"25","author":"Marruecos-Querol","year":"2023","journal-title":"Clin Transl Oncol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/lary.v122.5","article-title":"Talk score: development and validation of a prognostic model for predicting larynx preservation outcome","volume":"122","author":"Sherman","year":"2012","journal-title":"Laryngoscope"},{"key":"B45","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13061405","article-title":"Total laryngectomy-still cutting-edge","volume":"13","author":"Hoffmann","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B46","first-page":"24","article-title":"Endoscopic submucosal dissection for superficial Barrett's esophageal cancer in the Japanese state and perspective","volume":"2","author":"Ishihara","year":"2014","journal-title":"Ann Transl Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.5041\/RMMJ.20769172","article-title":"Assessment of margins in transoral laser and robotic surgery","volume":"5","author":"Hamzany","year":"2014","journal-title":"Rambam Maimonides Med J"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1058171","article-title":"Midline anterior craniofacial approach for Malignancy: results of en bloc versus piecemeal resections","volume":"9","author":"Wellman","year":"1999","journal-title":"Skull Base Surg"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/0196-0709(93)90050-H","article-title":"Results of curative laser microsurgery of laryngeal carcinomas","volume":"14","author":"Steiner","year":"1993","journal-title":"Am J Otolaryngol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoto.2015.1351","article-title":"Early oral tongue squamous cell carcinoma: sampling of margins from tumor bed and worse local control","volume":"141","author":"Maxwell","year":"2015","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-010-0083-6","article-title":"Quality initiatives in head and neck cancer","volume":"12","author":"Chen","year":"2010","journal-title":"Curr Oncol Rep"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1002\/(ISSN)1097-0347","article-title":"Surgical margin determination in head and neck oncology: current clinical practice: the results of an International American Head and Neck Society member survey","volume":"27","author":"Meier","year":"2005","journal-title":"Head Neck"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.v107:12","article-title":"Critical evaluation of frozen section margins in head and neck cancer resections","volume":"107","author":"Black","year":"2006","journal-title":"Cancer"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoto.2016.2329","article-title":"Association of main specimen and tumor bed margin status with local recurrence and survival in oral cancer surgery","volume":"142","author":"Buchakjian","year":"2016","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1111\/coa.14074","article-title":"Predictors of non-functional larynx following (chemo)radiotherapy for locally advanced laryngeal cancer","volume":"48","author":"Milinis","year":"2023","journal-title":"Clin Otolaryngol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"110281","DOI":"10.1016\/j.radonc.2024.110281","article-title":"A multicentric randomized controlled phase III trial of adaptive and 18F-FDG-PET-guided dose-redistribution in locally advanced head and neck squamous cell carcinoma (ARTFORCE)","volume":"196","author":"de Leeuw","year":"2024","journal-title":"Radiother Oncol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1080\/0284186X.2023.2245555","article-title":"A systematic review on clinical adaptive radiotherapy for head and neck cancer","volume":"62","author":"Lindegaard","year":"2023","journal-title":"Acta Oncol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.semradonc.2023.10.003","article-title":"The use of MR-guided radiation therapy for head and neck cancer and recommended reporting guidance","volume":"34","author":"McDonald","year":"2024","journal-title":"Semin Radiat Oncol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.radonc.2020.03.012","article-title":"SPECT\/CT-guided elective nodal irradiation for head and neck cancer is oncologically safe and less toxic: A potentially practice-changing approach","volume":"147","author":"de Veij Mestdagh","year":"2020","journal-title":"Radiother Oncol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"2807:2821","DOI":"10.1002\/hed.26713","article-title":"Unilateral versus bilateral nodal irradiation: Current evidence in the treatment of squamous cell carcinoma of the head and neck","volume":"43","author":"Nuyts","year":"2021","journal-title":"Head Neck"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2021.05.021","article-title":"Dose-escalated intensity-modulated radiotherapy in patients with locally advanced laryngeal and hypopharyngeal cancers: ART DECO, a phase III randomised controlled trial","volume":"153","author":"Nutting","year":"2021","journal-title":"Eur J Cancer"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-020-06012-9","article-title":"Moderate hypofractionation for early laryngeal cancer improves local control: a systematic review and meta-analysis","volume":"277","author":"Benson","year":"2020","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14361-9","article-title":"Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial","volume":"362","author":"Overgaard","year":"2003","journal-title":"Lancet"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1111\/imr.2017.280.issue-1","article-title":"Immune recognition of irradiated cancer cells","volume":"280","author":"Wennerberg","year":"2017","journal-title":"Immunol Rev"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.582884","article-title":"Therapy-induced modulation of the tumor microenvironment: new opportunities for cancer therapies","volume":"10","author":"Benavente","year":"2020","journal-title":"Front Oncol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"7015","DOI":"10.1038\/s41467-022-34676-w","article-title":"Elective nodal irradiation mitigates local and systemic immunity generated by combination radiation and immunotherapy in head and neck tumors","volume":"13","author":"Darragh","year":"2022","journal-title":"Nat Commun"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2023.05.006","article-title":"Proceed with caution: eliminating elective nodal irradiation with immunotherapy for head and neck cancer","volume":"117","author":"Schoenfeld","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2023.04.029","article-title":"High recurrence for HPV-positive oropharyngeal cancer with neoadjuvant radiation therapy to gross disease plus immunotherapy: analysis from a prospective phase Ib\/II clinical trial","volume":"117","author":"Ma","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-1695","article-title":"Neoadjuvant and adjuvant pembrolizumab in resectable locally advanced, human papillomavirus-unrelated head and neck cancer: A multicenter, phase II trial","volume":"26","author":"Uppaluri","year":"2020","journal-title":"Clin Cancer Res"},{"key":"B70","doi-asserted-by":"publisher","first-page":"7348","DOI":"10.1038\/s41467-021-26472-9","article-title":"Neoadjuvant immunotherapy with nivolumab and ipilimumab induces major pathological responses in patients with head and neck squamous cell carcinoma","volume":"12","author":"Vos","year":"2021","journal-title":"Nat Commun"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001378","article-title":"Safety and efficacy of single cycle induction treatment with cisplatin\/docetaxel\/ durvalumab\/tremelimumab in locally advanced HNSCC: first results of CheckRad-CD8","volume":"8","author":"Hecht","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.3390\/cancers13081959","article-title":"Implementation of double immune checkpoint blockade increases response rate to induction chemotherapy in head and neck cancer","volume":"13","author":"Semrau","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1097\/JS9.0000000000000489","article-title":"Neoadjuvant immunochemotherapy for locally advanced resectable oral squamous cell carcinoma: a prospective single-arm trial (Illuminate Trial)","volume":"109","author":"Huang","year":"2023","journal-title":"Int J Surg"},{"key":"B74","doi-asserted-by":"publisher","first-page":"5378","DOI":"10.1038\/s41467-022-33080-8","article-title":"A pilot study of neoadjuvant combination of anti-PD-1 camrelizumab and VEGFR2 inhibitor apatinib for locally advanced resectable oral squamous cell carcinoma","volume":"13","author":"Ju","year":"2022","journal-title":"Nat Commun"},{"key":"B75","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1186\/s13046-022-02510-2","article-title":"Neoadjuvant toripalimab combined with gemcitabine and cisplatin in resectable locally advanced head and neck squamous cell carcinoma (NeoTGP01): An open label, single-arm, phase Ib clinical trial","volume":"41","author":"Huang","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-0666","article-title":"Neoadjuvant chemoimmunotherapy for the treatment of locally advanced head and neck squamous cell carcinoma: A single-arm phase 2 clinical trial","volume":"28","author":"Zhang","year":"2022","journal-title":"Clin Cancer Res"},{"key":"B77","article-title":"Immuno-chemotherapy as single treatment modality for larynx preservation (ICoLP): Co-primary endpoints and safety results","volume":"41","author":"Renata","year":"2023","journal-title":"J Clin Oncol"},{"key":"B78","doi-asserted-by":"crossref","unstructured":"The European Larynx Organ Preservation Study [MK-3475-C44]\n          \n          \n            \n              Wichmann\n              G\n            \n            \n              Wald\n              T\n            \n            \n              Pirlich\n              M\n            \n            \n              Napp\n              J\n            \n            \n              M\u00fcnter\n              I\n            \n            \n              Asendorf\n              T\n            \n          \n          Front Oncol.\n          14\n          2024","DOI":"10.3389\/fonc.2024.1433238"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1494854\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T08:48:55Z","timestamp":1744793335000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1494854\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,17]]},"references-count":78,"alternative-id":["10.3389\/fonc.2024.1494854"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2024.1494854","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,17]]},"article-number":"1494854"}}